Skip to main content

Market Overview

Oncternal Therapeutics, Inc. (ONCT)

6.24 -0.40 (-6.02%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2021
After-Hours
EPS:
REV:




Q3 2021
After-Hours
EPS:
REV:
-0.22
585K



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.31
578K



Q4 2020
After-Hours
EPS:
REV:
-0.27
737K
-0.18
590K
-0.09
1.588M
50%
169.15%
Q3 2020
After-Hours
EPS:
REV:
-0.32
544K

-0.22
585K

Q2 2020
After-Hours
EPS:
REV:
-3.38
674K

-0.34
623K

Q1 2020
Pre-Market
EPS:
REV:


-0.31
578K

Q4 2019
After-Hours
EPS:
REV:
-0.21
477K

-0.27
737K

Q3 2019
After-Hours
EPS:
REV:

329K

-0.32
544K

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!